[1] |
Bi J, Wu S, Zhang W, et al. Targeting cancer′s metabolic co⁃dependencies: a landscape shaped by genotype and tissue context[J]. Biochim Biophys Acta Rev Cancer, 2018,1870(1):76⁃87. doi: 10.1016/j.bbcan.2018.05.002.
|
[2] |
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation[J]. Cell, 2011,144(5):646⁃674. doi: 10.1016/j.cell. 2011.02.013.
|
[3] |
Kuo MH, Chang WW, Yeh BW, et al. Glucose transporter 3 is essential for the survival of breast cancer cells in the brain[J]. Cells, 2019,8(12):1568. doi: 10.3390/cells8121568.
|
[4] |
Mei T, Wang Z, Wu J, et al. Expression of GLUT3 and HIF⁃1α in meningiomas of various grades correlated with peritumoral brain edema[J]. Biomed Res Int, 2020,2020:1682352. doi: 10.1155/2020/1682352.
|
[5] |
Wang Y, Li W, Zhang Q, et al. Targeting phosphorylation of p21⁃activated kinase 1 at Thr423 induces cell cycle arrest and apoptosis in cutaneous T⁃cell lymphoma cells[J]. Acta Derm Venereol, 2019,99(11):1022⁃1028. doi: 10.2340/00015555⁃3263.
|
[6] |
Leng Y, Yi M, Fan J, et al. Effects of acute intra⁃abdominal hypertension on multiple intestinal barrier functions in rats[J]. Sci Rep, 2016,6:22814. doi: 10.1038/srep22814.
|
[7] |
王祥宇, 郑燕, 鲁明. 肿瘤代谢与肿瘤转移[J]. 复旦学报(医学版), 2016,43(1):86⁃93. doi: 10.3969/j.issn.1672⁃8467.2016. 01.016.
|
[8] |
Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism[J]. Cell Metab, 2016,23(1):27⁃47. doi: 10.1016/j.cmet.2015.12.006.
|
[9] |
Warburg O. On the origin of cancer cells[J]. Science, 1956,123(3191):309⁃314. doi: 10.1126/science.123.3191.309.
|
[10] |
李博. 肿瘤糖代谢紊乱的研究进展和探索[J]. 中山大学学报(医学科学版), 2017,38(2):222⁃228.
|
[11] |
刘戈, 宋关斌. 肿瘤细胞的糖代谢调控与肿瘤治疗[J]. 生物医学工程学杂志, 2019,36(04):691⁃695. doi: 10.7507/1001⁃5515.201812025.
|
[12] |
Simon⁃Molas H, Vallvé⁃Martínez X, Caldera⁃Quevedo I, et al. TP53⁃induced glycolysis and apoptosis regulator (TIGAR) is upregulated in lymphocytes stimulated with concanavalin A[J]. Int J Mol Sci, 2021,22(14):7436. doi: 10.3390/ijms22147436.
|
[13] |
Barron CC, Bilan PJ, Tsakiridis T, et al. Facilitative glucose transporters: implications for cancer detection, prognosis and treatment[J]. Metabolism, 2016,65(2):124⁃139. doi: 10.1016/j.metabol.2015.10.007.
|
[14] |
Benarroch EE. Brain glucose transporters: implications for neurologic disease[J]. Neurology, 2014,82(15):1374⁃1379. doi: 10.1212/WNL.0000000000000328.
|
[15] |
Maher F, Vannucci S, Takeda J, et al. Expression of mouse⁃GLUT3 and human⁃GLUT3 glucose transporter proteins in brain[J]. Biochem Biophys Res Commun, 1992,182(2):703⁃711. doi: 10.1016/0006⁃291x(92)91789⁃s.
|
[16] |
Peng W, Tan C, Mo L, et al. Glucose transporter 3 in neuronal glucose metabolism: health and diseases[J]. Metabolism, 2021,123:154869. doi: 10.1016/j.metabol.2021.154869.
|
[17] |
Stuart CA, Wen G, Jiang J. GLUT3 protein and mRNA in autopsy muscle specimens[J]. Metabolism, 1999,48(7):876⁃880. doi: 10.1016/s0026⁃0495(99)90222⁃6.
|
[18] |
Fidler TP, Campbell RA, Funari T, et al. Deletion of GLUT1 and GLUT3 reveals multiple roles for glucose metabolism in platelet and megakaryocyte function[J]. Cell Rep, 2017,20(4):881⁃894. doi: 10.1016/j.celrep.2017.06.083.
|
[19] |
Feitosa SG, Viana KF, Luna E, et al. Immunohistochemical evaluation of GLUT⁃3 and GLUT⁃4 in oral epithelial dysplasia and oral squamous cell carcinoma[J]. Asian Pac J Cancer Prev, 2018,19(7):1779⁃1783. doi: 10.22034/APJCP.2018.19.7.1779.
|
[20] |
Contat C, Ancey PB, Zangger N, et al. Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth[J]. Elife, 2020,9:e53618. doi: 10.7554/eLife.53618.
|
[21] |
Jóźwiak P, Krześlak A, Pomorski L, et al. Expression of hypoxia⁃related glucose transporters GLUT1 and GLUT3 in benign, malignant and non⁃neoplastic thyroid lesions[J]. Mol Med Rep, 2012,6(3):601⁃606. doi: 10.3892/mmr.2012.969.
|
[22] |
Krzeslak A, Wojcik⁃Krowiranda K, Forma E, et al. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers[J]. Pathol Oncol Res, 2012,18(3):721⁃728. doi: 10.1007/s12253⁃012⁃9500⁃5.
|
[23] |
Gao H, Hao Y, Zhou X, et al. Prognostic value of glucose transporter 3 expression in hepatocellular carcinoma[J]. Oncol Lett, 2020,19(1):691⁃699. doi: 10.3892/ol.2019.11191.
|
[24] |
Ayala FR, Rocha RM, Carvalho KC, et al. GLUT1 and GLUT3 as potential prognostic markers for oral squamous cell carcinoma[J]. Molecules, 2010,15(4):2374⁃2387. doi: 10.3390/molecules 15042374.
|
[25] |
Baer S, Casaubon L, Schwartz MR, et al. Glut3 expression in biopsy specimens of laryngeal carcinoma is associated with poor survival[J]. Laryngoscope, 2002,112(2):393⁃396. doi: 10.1097/00005537⁃200202000⁃00034.
|
[26] |
Libby CJ, Gc S, Benavides GA, et al. A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1[J]. Cell Adh Migr, 2021,15(1):101⁃115. doi: 10.1080/19336918. 2021.1903684.
|
[27] |
Kuo CC, Ling HH, Chiang MC, et al. Metastatic colorectal cancer rewrites metabolic program through a Glut3⁃YAP⁃dependent signaling circuit[J]. Theranostics, 2019,9(9):2526⁃2540. doi: 10.7150/thno.32915.
|
[28] |
Korgun ET, Celik⁃Ozenci C, Seval Y, et al. Do glucose transporters have other roles in addition to placental glucose transport during early pregnancy?[J]. Histochem Cell Biol, 2005,123(6):621⁃629. doi: 10.1007/s00418⁃005⁃0792⁃3.
|
[29] |
Xia S, Lal B, Tung B, et al. Tumor microenvironment tenascin⁃C promotes glioblastoma invasion and negatively regulates tumor proliferation[J]. Neuro Oncol, 2016,18(4):507⁃517. doi: 10.1093/ neuonc/nov171.
|
[30] |
Jan HJ, Lee CC, Shih YL, et al. Osteopontin regulates human glioma cell invasiveness and tumor growth in mice[J]. Neuro Oncol, 2010,12(1):58⁃70. doi: 10.1093/neuonc/nop013.
|
[31] |
Pietras A, Katz AM, Ekström EJ, et al. Osteopontin⁃CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth[J]. Cell Stem Cell, 2014,14(3):357⁃369. doi: 10.1016/j.stem.2014.01.005.
|
[32] |
Shi W, Fu Y, Wang Y. Downregulation of GLUT3 impairs STYK1/NOK⁃mediated metabolic reprogramming and proliferation in NIH⁃3T3 cells[J]. Oncol Lett, 2021,22(1):527. doi: 10.3892/ol.2021.12788.
|
[33] |
Colegio OR, Chu NQ, Szabo AL, et al. Functional polarization of tumour⁃associated macrophages by tumour⁃derived lactic acid[J]. Nature, 2014,513(7519):559⁃563. doi: 10.1038/nature13490.
|
[34] |
Goodwin ML, Jin H, Straessler K, et al. Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment[J]. Cancer Cell, 2014,26(6):851⁃862. doi: 10.1016/j.ccell.2014.10.003.
|